Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin
- 6 May 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 112 (9), 2508-2517
- https://doi.org/10.1002/jcb.23175
Abstract
EGFR is a potent stimulator of invasion and metastasis in head and neck squamous cell carcinomas (HNSCC). However, the mechanism by which EGFR may stimulate tumor cell invasion and metastasis still need to be elucidated. In this study, we showed that activation of EGFR by EGF in HNSCC cell line SCC10A enhanced cell migration and invasion, and induced loss of epitheloid phenotype in parallel with downregulation of E‐cadherin and upregulation of N‐cadherin and vimentin, indicating that EGFR promoted SCC10A cell migration and invasion possibly by an epithelial to mesenchymal transition (EMT)‐like phenotype change. Interestingly, activation of EGFR by EGF induced production of matrix metalloproteinase‐9 (MMP‐9) and soluble E‐cadherin (sE‐cad), and knockdown of MMP‐9 by siRNA inhibited sE‐cad production induced by EGF in SCC10A. Moreover, both MMP‐9 knockdown and E‐cadherin overexpression inhibited cell migration and invasion induced by EGF in SCC10A. The results indicate that EGFR activation promoted cell migration and invasion through inducing MMP‐9‐mediated degradation of E‐cadherin into sE‐cad. Pharmacologic inhibition of EGFR, MEK, and PI3K kinase activity in SCC10A reduced phosphorylated levels of ERK‐1/2 and AKT, production of MMP‐9 and sE‐cad, cell migration and invasion, and expressional changes of EMT markers (E‐cadherin and N‐cadherin) induced by EGF, indicating that EGFR activation promotes cell migration and invasion via ERK‐1/2 and PI3K‐regulated MMP‐9/E‐cadherin signaling pathways. Taken together, the data suggest that EGFR activation promotes HNSCC SCC10A cell migration and invasion by inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin into sE‐cad related to activation of ERK‐1/2 and PI3K signaling pathways. J. Cell. Biochem. 112: 2508–2517, 2011.Keywords
This publication has 44 references indexed in Scilit:
- Emerging drugs to treat squamous cell carcinomas of the head and neckEmerging Drugs, 2010
- New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor InhibitorsClinical Cancer Research, 2010
- TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinomaOncogene, 2010
- Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2009
- Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureBMC Cancer, 2009
- Identification of RKIP as an Invasion Suppressor Protein in Nasopharyngeal Carcinoma by Proteomic AnalysisJournal of Proteome Research, 2008
- Hypermethylation of E‐cadherin is an independent predictor of improved survival in head and neck squamous cell carcinomaCancer, 2008
- Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neckBritish Journal of Cancer, 2007
- Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell, 1991